Cash position of €6.7m at May 31, 2023 strengthened by USD 2.5m received from the joint venture with Tasly Pharmaceutical Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (OTCQX:MKEAY)
Regulatory News: At its meeting of April 5, 2023, the Board of Directors of Mauna Kea Technologies (Euronext Paris, ISIN: FR0010609263, MKEA VIC) (OTCQX:MKEAY) (the "Company"), inventor of the Cellvizio
Proposed Transfer of the Listing of Mauna Kea Technologies' Shares to the Euronext Growth Paris Market streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Recognition of first revenues from the Joint Venture with Tasly Pharmaceutical Regulatory News: Mauna Kea Technologies (Euronext: MKEA), inventor of the Cellvizio, the multidisciplinary probe
Mauna Kea Technologies Reports 2022 Annual Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.